Alan Scott Enterprises Ltd
Incorporated in 1994, Alan Scott Industries manufacture health and hygiene products for use in hospitals and homes
- Market Cap ₹ 106 Cr.
- Current Price ₹ 194
- High / Low ₹ 200 / 47.0
- Stock P/E
- Book Value ₹ 3.28
- Dividend Yield 0.00 %
- ROCE 3.88 %
- ROE -64.7 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Promoter holding has increased by 2.83% over last quarter.
Cons
- Stock is trading at 59.1 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -94.3% over last 3 years.
- Earnings include an other income of Rs.2.25 Cr.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|
0.02 | 1.24 | 5.17 | 11.42 | 28.69 | 31.98 | |
0.11 | 1.90 | 5.60 | 11.47 | 26.75 | 29.38 | |
Operating Profit | -0.09 | -0.66 | -0.43 | -0.05 | 1.94 | 2.60 |
OPM % | -450.00% | -53.23% | -8.32% | -0.44% | 6.76% | 8.13% |
0.09 | 0.67 | 0.06 | 0.35 | 2.25 | 2.25 | |
Interest | 0.00 | 0.02 | 0.61 | 1.38 | 2.20 | 2.34 |
Depreciation | 0.00 | 0.05 | 1.08 | 2.41 | 3.80 | 3.82 |
Profit before tax | 0.00 | -0.06 | -2.06 | -3.49 | -1.81 | -1.31 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | ||
0.00 | -0.07 | -2.06 | -3.50 | -1.82 | -1.33 | |
EPS in Rs | 0.00 | -0.11 | -3.50 | -5.93 | -3.07 | -1.97 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 185% |
TTM: | 92% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 67% |
Stock Price CAGR | |
---|---|
10 Years: | 33% |
5 Years: | 79% |
3 Years: | 41% |
1 Year: | 298% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -94% |
Last Year: | -65% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
Equity Capital | 1.19 | 1.83 | 1.83 | 3.62 | 3.63 |
Reserves | 0.35 | 1.25 | -0.64 | -0.26 | -1.86 |
0.05 | 0.17 | 3.00 | 8.62 | 7.38 | |
0.00 | 2.32 | 6.20 | 15.87 | 18.10 | |
Total Liabilities | 1.59 | 5.57 | 10.39 | 27.85 | 27.25 |
0.00 | 2.60 | 6.01 | 15.03 | 15.82 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.30 | 0.21 | 0.21 | 0.89 | 1.36 |
1.29 | 2.76 | 4.17 | 11.93 | 10.07 | |
Total Assets | 1.59 | 5.57 | 10.39 | 27.85 | 27.25 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
0.18 | -1.58 | -2.78 | -3.11 | -0.32 | |
-0.21 | -0.95 | 0.31 | -3.05 | -1.26 | |
1.29 | 1.73 | 2.15 | 8.53 | -0.15 | |
Net Cash Flow | 1.26 | -0.80 | -0.33 | 2.37 | -1.74 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
Debtor Days | 0.00 | 2.94 | 0.71 | 13.10 | 7.89 |
Inventory Days | 124.03 | 227.11 | 211.75 | 88.66 | |
Days Payable | 88.59 | 107.76 | 126.84 | 15.87 | |
Cash Conversion Cycle | 0.00 | 38.38 | 120.06 | 98.01 | 80.68 |
Working Capital Days | -730.00 | 73.59 | -46.60 | -70.63 | 26.33 |
ROCE % | -27.63% | -35.79% | -26.39% | 3.88% |
Documents
Announcements
-
Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended June 30, 2025.
29 Jul - No deviation in utilization of INR 726.34 lakh rights issue proceeds for planned investments.
- Submission Of Unaudited Standalone & Consolidated Financial Results For The Quarter Ended June 30, 2025 Along With Limited Review Report Of The Auditors As Per Regulation 33 Of SEBI (Listing Obligations And Disclosures Requirements), Regulations 2015. 29 Jul
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, July 29, 2025 At 11:10 Am (IST) At The Registered Office Of The Company.
29 Jul - Q1 2025 financial results approved; Ambarish R. Sodha appointed additional independent director.
-
Announcement under Regulation 30 (LODR)-Acquisition
24 Jul - Alan Scott Enterprises acquires controlling stakes in 2 firms, sets up 2 subsidiaries in AI and tech sectors.
-
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2025.
22 Jul - Board meeting on July 29 to approve Q1 June 2025 unaudited financial results.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2012
from bse
-
Financial Year 2006
from bse
-
Financial Year 2005
from bse
-
Financial Year 2004
from bse
Product Profile:
a) 5 petals AIR purifier+[1]
This uses 8 different technologies instead of 5 certified technologies to provide protection from aerosol spread of 99.9% of Virus, Bacteria, fungus and Yeasts
b) 5 Petals O2 Concentrator[2]
It's a supplement of oxygen with a capacity
of 8-25 LPM and a High Purity Oxygen 90-95%
Clientele:[3]
Larsen & Tubro, Som Capital, Rubix,
Thought Bridge HR, Verstech, Sunicon, Sanjivani Parentrals3